Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Resea...( Foundation Continues Research Initiat...)

Foundation Continues Research Initiatives in Search of a Cure and Therapies

for Paralysis

SHORT HILLS, N.J., Jan. 31 /PRNewswire/ -- The Christopher and Dana Reeve Foundation (CDRF), which is dedicated to curing spinal cord injury by funding innovative research and improving the quality of life for people living with paralysis through grants, information and advocacy, today announced it has awarded $1,996,745 million to 16 laboratories through its Individual Research Grants Program. At the forefront of molecular and cellular studies, CDRF's Individual Research Grant Program is the Foundation's largest, most comprehensive research initiative. The grants awarded today represent an overall $77 million commitment to research by the Foundation since 1982.

"The Individual Grants Research Program plays an integral role in allowing scientists to gather the preliminary data necessary to secure larger, more long-term support from the National Institutes of Health (NIH) and other funding agencies," said Susan Howley, Director of Research and Executive Vice President of CDRF. "Supporting this kind of basic research is the key to the development of therapies for paralysis caused by spinal cord injury and a host of other central nervous system disorders."

Each of the CDRF grant recipients will use the money to fund research that supports investigator-initiated research on a variety of fronts, including axon growth and guidance, remyelination, cellular replacement, rehabilitation and neuroprotection.

"From brain-controlled prosthetics and stem cell manipulation to the use of non-spinal cord injury drugs to regenerate nerve fibers, this year, the grants represent a diverse portfolio, including many rehabilitation grants which prove that translation research is moving forward," said Moses Chao, Ph.D., Professor of Cell Biology and Neuroscience at NYU School of Medicine and Chairman of CDRF's Science Advisory Council. "I
'/>"/>